Hematological malignancy burden in mainland China and Taiwan from 1990 to 2021 and decadal projections: Insights from the global burden of disease study 2021.
<h4>Objectives</h4>Hematological malignancies (HMs) pose a severe threat to human health and contribute substantially to the disease burden in mainland China and Taiwan. Therefore, understanding their burden is crucial for informed decision-making and the effective allocation of healthca...
Saved in:
Main Authors: | Yu Fu, Ya-Zhe Du, Yun-Wei Zhang, Fei Song, Su-Jun Gao, Long Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0328526 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hematological malignancy burden in mainland China and Taiwan from 1990 to 2021 and decadal projections: Insights from the global burden of disease study 2021
by: Yu Fu, et al.
Published: (2025-01-01) -
Global, regional, and national economic burden of hematologic malignancies (1990–2021) with projections to 2050
by: Zhexian Li, et al.
Published: (2025-06-01) -
The global burden of osteoarthritis hand: lessons from the Global Burden of Disease Study 1990–2021
by: Jiyong Wei, et al.
Published: (2025-07-01) -
Global Burden of Lip and Oral Cavity Cancer From 1990 to 2021 and Projection to 2040: Findings From the 2021 Global Burden of Disease Study
by: Mingxing Chen, et al.
Published: (2025-05-01) -
The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021
by: Xin-Zheng Hou, et al.
Published: (2025-06-01)